Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 26, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

What is the patent landscape for Testosterone, and what generic Testosterone alternatives are available?

Testosterone is a drug marketed by Watson Labs, Actavis Labs Ut Inc, Par Pharm, Perrigo Israel, Ani Pharms Inc, Sandoz Inc, Sun Pharm Inds Ltd, Paddock Llc, Watson Pharms Inc, Hikma Farmaceutica, Mylan Institutional, West-ward Pharms Int, Bel Mar, Lilly, and Elkins Sinn. and is included in thirty-six NDAs.

The generic ingredient in TESTOSTERONE is testosterone propionate. There are sixty-one drug master file entries for this compound. There is one tentative approval for this compound. Additional details are available on the testosterone propionate profile page.

Summary for Tradename: TESTOSTERONE

Suppliers / Packagers: see list3
Bulk Api Vendors: see list52
Clinical Trials: see list294
Patent Applications: see list9,832
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TESTOSTERONE at DailyMed

Pharmacology for Tradename: TESTOSTERONE

Drug ClassAndrogen
Mechanism of ActionAndrogen Receptor Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bel Mar
testosterone propionate
INJECTABLE;INJECTION080742-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Mylan Institutional
testosterone enanthate
INJECTABLE;INJECTION040647-001Oct 5, 2009AORXNoNo► Subscribe► Subscribe
Watson Labs
testosterone propionate
INJECTABLE;INJECTION085490-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Watson Labs
testosterone propionate
INJECTABLE;INJECTION080188-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Watson Labs
testosterone propionate
INJECTABLE;INJECTION083595-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Find generic sources and suppliers
  • Formulary management

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus